Medicare to negotiate prices for top drugs
Medicare announced plans to negotiate lower prices for 15 costly drugs, including Ozempic, Wegovy, and Trelegy Ellipta, starting in 2027. These medications, used for conditions like diabetes, weight loss, and asthma, accounted for $41 billion in Medicare spending last year. Novo Nordisk’s drugs alone cost $14.4 billion.
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
The median wait time between referral and appointment was 34 days, and 18 percent of patients waited more than 90 days, the ...
Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be ...
The first openly trans member of Congress reflects on how her experience with love and loss taught her to pursue change from ...
Monday’s Forbes Daily revisits Forbes’ best reporting on the incoming Trump Administration, including China’s meetings in D.C., advice for your investment portfolio and more.
During President Donald Trump's first term in office, the national debt increased by $8 trillion—due, in large part, to huge spending hikes that Congress passed and Trump signed.
To corral costs, Keith is leading a new initiative at BCBSM called Blue Cross Accelerated that aims to cut $600 million in ...
Seniors are more than a quarter of the electorate - 27% - and a slim majority of them - 51% - voted for Donald Trump in November. With Trump moving back into his old digs at 1600 Pennsylvania Ave., ...
With Donald Trump's election and Democratic minorities in every branch of government, U.S. Rep. Richard Neal and his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback